Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face

NACompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

May 26, 2020

Study Completion Date

May 26, 2020

Conditions
Signs of Facial Aging With Volume Loss in the Upper Cheeks, Nasolabial Folds and Marionette Lines
Interventions
DEVICE

RADIESSE® (+) Lidocaine

RADIESSE® (+) Lidocaine will be injected as per its current approved labelling and investigator's usual practice

Trial Locations (7)

14467

Haut-und Lasercentrum, Merz Investigational Site #0490362, Potsdam

20146

Universität Hamburg Fachbereich Chemie Institut für Biologie und Molekularbiologie , Merz Investigational Site #490095, Hamburg

22609

Derma Science GmbH Hamburg, Merz Investigational Site #490345, Hamburg

42287

Centroderm GmbH, Merz Investigational Site #490367, Wuppertal

64283

Rosenpark Research, Merz Investigational Site #490099, Darmstadt

80539

Privatpraxis für Dermatologie und Ästhetik, Merz Investigational Site #490371, Munich

80636

Dermatologie München-Neuhausen, Merz Investigational Site #490372, Munich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Merz Pharmaceuticals GmbH

INDUSTRY

lead

Merz North America, Inc.

INDUSTRY

NCT03650387 - Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face | Biotech Hunter | Biotech Hunter